Venetoclax + hypomethylating agents combined with dose-adjusted HAG for relapsed/refractory acute myeloid leukemia: Two case reports

RATIONALE: Some acute myeloid leukemia (AML) patients are unresponsive to treatment or have remission followed by worsening of disease (known as relapsed/refractory AML [R/RAML]) after standardized treatment. The CAG/HAG regimen is not often used clinically because heterogenous patient responses, re...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Medicine (Baltimore)
Hauptverfasser: Wang, Hongxia, Bai, Junjun, Pei, Zhixin, Zhang, Bei, Wang, Junjie, Lian, Xingli, Song, Qinglin
Format: Artigo
Sprache:Inglês
Veröffentlicht: Lippincott Williams & Wilkins 2020
Schlagworte:
4800
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7676608/
https://ncbi.nlm.nih.gov/pubmed/33217852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000023265
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge